Source: Chen S, Zhang Z, Zheng X, Tao H, Zhang S, Ma J, Liu Z, Wang J, Qian Y, Cui P, Huang D, Huang Z, Wu Z, Hu Y. Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer (PAROLA)

Authors : ARCAGY/ GINECO GROUP; European Network of Gynaecological Oncological Trial Groups (ENGOT); Gynecologic Cancer Intergroup (GCIG)

Source: PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

Authors : Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group

Source: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (≥ 4 cm) - IIIA Non-small Cell Lung

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Authors : Gateway for Cancer Research; Yuanquan Yang, Principal Investigator

Source: A Phase II Trial of Futibatinib in Combination With Durvalumab Administered to Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer Before Cystectomy

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER) (PIPER)

Authors : Cancer Research Malaysia; Merck Sharp & Dohme LLC; Kuala Lumpur General Hospital ...

Source: A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Authors : Conquer Cancer Foundation; Gateway for Cancer Research; Prostate Cancer Foundation ...

Source: A Phase 2 Study of 68Ga-PSMA-11 PET in Patients With Metastatic Castration Resistant Prostate Cancer

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder (ADAPT-BLADDER)

Authors : AstraZeneca; Hoosier Cancer Research Network; Noah Hahn, M.D., Sponsor-Investigator

Source: PhAse 1/2 StuDy of Modern ImmunotherApy in BCG-Unresponsive, BCG-RelaPsing, and High-Risk BCG-Naive Non-muscle Invasive UroThelial Carcinoma of the BLADDER

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Authors : Breast Cancer Research Foundation

Source: A Phase II Trial to Evaluate Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Authors : A Glimmer of Hope Foundation; Breast Cancer Research Foundation; Emilia J Diego, MD, Associate Professor of Surgery

Source: A Clinical Study of a Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer (InCITe)

Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (CYBRID-02)

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer (PAROLA)

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER) (PIPER)

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder (ADAPT-BLADDER)

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

اتصل بنا

اتبع